The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis
Part of paid clinical trials in Sacramento, California.
- Sponsor
- Integrative Skin Science and Research
- Study ID
- NCT05942248
- Status
- Recruiting
Conditions
- Acne
- Melasma
- Rosacea
- Seborrheic Dermatitis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- No Intervention — OTHERNo Intervention
Study Details
The study is conducted to determine if image-based computer grading can of acne, melasma, rosacea and seborrheic dermatitis correlate well to expert based clinical severity grading.
Key Dates
- Start date
- Jun 6, 2023
- Status verified
- Aug 2024
- Primary completion
- Jan 31, 2025
- Completion
- Feb 28, 2025
Study Design
- Enrollment
- 150 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Other: Acne vulgarisInflammatory and non-inflammatory lesion counts
- Other: RosaceaInflammatory lesion count
- Other: MelasmaPigment intensity and distribution with use of Melasma Area Severity Index
- Other: Seborrheic DermatitisGrading of seborrheic dermatitis with Seborrheic Dermatitis Area Severity Index score
Primary Outcome Measure
Correlation of image-based grading to clinical gradings for acne [ Time Frame: Baseline ]
Central Contacts
- Raja Sivamani, MD, MS, AP916-750-2463
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Integrative Skin and Research | Sacramento | California | 95815 |
Find similar trials in Sacramento, CA
By research site
Related Studies
- Effects of Oral Supplement Containing L-Histidine and Antioxidants on the Skin Barrier Function and Systemic Inflammation in RosaceaRecruiting · Integrative Skin Science and Research · Sacramento, California
- Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe AcnePHASE1/PHASE2 · Recruiting · Sanofi Pasteur, a Sanofi Company · Scottsdale, Arizona
- Exploring Acne Treatments Through Clinical Research ParticipationNot Yet Recruiting · Power Life Sciences Inc. · San Francisco, California
- Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild AcnePHASE1/PHASE2 · Recruiting · Sanofi Pasteur, a Sanofi Company · Encino, California